Horse Epithelia
NDC 22840-5106, Equus caballus, solution, from Greer Laboratories, Inc..
- Product NDC
- 22840-5106
- Status
- Listed
- Labeler
- Greer Laboratories, Inc.
- Dosage form
- SOLUTION
- Route
- INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
- Product type
- NON-STANDARDIZED ALLERGENIC
- Marketing category
- BLA
- Application
- BLA101833
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/22840-5106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EQUUS CABALLUS SKIN.05 g/mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Cells, Epidermal [EXT]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Animal Skin Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 22840-5106-2 | 22840510602 | 10 mL in 1 VIAL, MULTI-DOSE (22840-5106-2) |
| 22840-5106-4 | 22840510604 | 50 mL in 1 VIAL, MULTI-DOSE (22840-5106-4) |
| 22840-5106-5 | 22840510605 | 5 mL in 1 BOTTLE, DROPPER (22840-5106-5) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 22840-5106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/22840-5106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 22840-5106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.